Molecular and macromolecular alterations of recombinant adenoviral vectors do not resolve changes in hepatic drug metabolism during infection

Virology Journal

Volumn 5, Issue , 2008, Pages

  Callahan, Shellie M ^a   Wonganan, Piyanuch ^a   Croyle, Maria A ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; CYTOCHROME P450 2C11; CYTOCHROME P450 3A2; CYTOCHROME P450 3A4; MESSENGER RNA; OLIGONUCLEOTIDE; RIBOFLAVIN; ALANINE AMINOTRANSFERASE; CYP2C11 PROTEIN, RAT; CYP3A2 PROTEIN, RAT; MEMBRANE PROTEIN; STEROID 16ALPHA MONOOXYGENASE; UNSPECIFIC MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME REPRESSION; GENE AMPLIFICATION; GENE SEQUENCE; HEPATITIS; IMMUNE RESPONSE; IMMUNOLOGY; IN VITRO STUDY; MACROMOLECULE; MALE; MICROARRAY ANALYSIS; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; VIRUS GENE; VIRUS INFECTION; WILD TYPE; ADENOVIRUS; ANIMAL; BLOOD; CELL CULTURE; CELL LINE; ENZYMOLOGY; GENE EXPRESSION; GENE VECTOR; GENETICS; HUMAN; LIVER; LIVER CELL; METABOLISM; VIROLOGY;

ADENOVIRIDAE; RATTUS;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ALANINE TRANSAMINASE; ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CELL LINE; CELLS, CULTURED; GENE EXPRESSION; GENETIC VECTORS; HEPATOCYTES; HUMANS; LIVER; MALE; MEMBRANE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; STEROID 16-ALPHA-HYDROXYLASE;

EID: 53749084130     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-5-111     Document Type: Article

References (60)

1. Cytochrome P450 enzyme isoforms and their therapeutic implications: an update. BS Kalra, Indian J Med Sci 2007 61 102 116 17259690
2. Cytochrome P450s and other enzymes in drug metabolism and toxicity. FP Guengerich, AAPS J 2006 8 E101 E111 16584116
3. The Effect of Cytochrome P450 Metabolism on Drug Response, Interactions, and Adverse Effects. T Lynch A Price, Am Fam Physicians 2007 76 391 396
4. Cytochrome p450 and chemical toxicology. FP Guengerich, Chem Res Toxicol 2008 21 70 83 18052394
5. Regulation of drug metabolism and disposition during inflammation and infection. KW Renton, Expert Opin Drug Metab Toxicol 2005 1 629 640 16863429
6. Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. ET Morgan KB Goralski M Piquette-Miller KW Renton GR Robertson MR Chaluvadi KA Charles SJ Clarke M Kacevska C Liddle TA Richardson R Sharma CJ Sinal, Drug Metab Dispos 2008 36 205 216 18218849
7. Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring. SF Zhou CC Xue XQ Yu C Li G Wang, Ther Drug Monit 2007 29 687 710 18043468
8. Toxicological significance of mechanism-based inactivation of cytochrome p450 enzymes by drugs. Y Masubuchi T Horie, Crit Rev Toxicol 2007 37 389 412 17612953
9. Considerations for use of recombinant adenoviral vectors: dose effect on hepatic cytochromes P450. SM Callahan X Ming SK Lu LJ Brunner MA Croyle, J Pharmacol Exp Ther 2005 312 492 501 15496614
10. Impact of transgene expression on drug metabolism following systemic adenoviral vector administration. SM Callahan MP Boquet X Ming LJ Brunner MA Croyle, J Gene Med 2006 8 566 576 16508909
11. Association of viral genome with graft loss in children after cardiac transplantation. GS Shirali J Ni RE Chinnock JK Johnston GL Rosenthal NE Bowles JA Towbin, N Engl J Med 2001 344 1498 1503 11357152
12. Viral infections in obstructive airway diseases. TA Seemungal JA Wedzicha, Curr Opin Pulm Med 2003 9 111 116 12574690
13. Respiratory viral infections drive chemokine expression and exacerbate the asthmatic response. M Schaller CM Hogaboam N Lukacs SL Kunkel, J Allergy Clin Immunol 2006 118 295 302 16890750
14. Reactivation of Viruses in Solid Organ Transplant Patients Receiving Cytomegalovirus Prophylaxis. A Humar, Transplantation 2006 82 S9 S14 16858271
15. PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver. MA Croyle N Chirmule Y Zhang JM Wilson, Hum Gene Ther 2002 13 1887 1900 12396620
16. "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung. MA Croyle N Chirmule Y Zhang JM Wilson, J Virol 2001 75 4792 4801 11312351
17. Adenoviral vectors for gene therapy. JT Douglas, Mol Biotechnol 2007 36 71 80 17827541
18. PXR and CAR: nuclear receptors which play a pivotal role in drug disposition and chemical toxicity. LA Stanley BC Horsburgh J Ross N Scheer CR Wolf, Drug Metab Rev 2006 38 515 597 16877263
19. Transcriptional regulation and expression of CYP3A4 in hepatocytes. CP Martínez-Jiménez R Jover MT Donato JV Castell MJ Gómez-Lechón, Curr Drug Metab 2007 8 185 194 17305497
20. Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons. N Morral WK O'Neal K Rice MM Leland PA Piedra E Aguilar-Cordova KD Carey AL Beaudet C Langston, Hum Gene Ther 2002 13 143 154 11779418
21. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. SE Raper N Chirmule FS Lee NA Wivel A Bagg GP Gao JM Wilson ML Batshaw, Mol Genet Metab 2003 80 148 158 14567964
22. Endocrine disruptors induce cytochrome P450 by affecting transcriptional regulation via pregnane × receptor. E Mikamo S Harada J Nishikawa T Nishihara, Toxicol Appl Pharmacol 2003 193 66 72 14613717
23. Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospects. MP Seiler V Cerullo B Lee, Curr Gene Ther 2007 7 297 305 17979676
24. Elimination of innate immune responses and liver inflammation by PEGylation of adenoviral vectors and methylprednisolone. B De Geest J Snoeys S Van Linthout J Lievens D Collen, Hum Gene Ther 2005 16 1439 1451 16390275
25. Polyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopenia. SE Hofherr H Mok FC Gushiken JA Lopez MA Barry, Hum Gene Ther 2007 18 837 848 17767399
26. CAR and PXR: the xenobiotic-sensing receptors. YE Timsit M Negishi, Steroids 2007 72 231 246 17284330
27. RAR and RXR modulation in cancer and metabolic disease. L Altucci MD Leibowitz KM Ogilvie AR de Lera H Gronemeyer, Nat Rev Drug Discov 2007 6 793 810 17906642
28. Interplay of pregnane × receptor with other nuclear receptors on gene regulation. YP Lim JD Huang, Drug Metab Pharmacokinet 2008 23 14 21 18305371
29. Hepatic cytochrome P450 gene regulation during endotoxin-induced inflammation in nuclear receptor knockout mice. TA Richardson ET Morgan, J Pharmacol Exp Ther 2005 314 703 709 15860574
30. Phosphorylation of native and heme-modified CYP3A4 by protein kinase C: a mass spectrometric characterization of the phosphorylated peptides. X Wang KF Medzihradszky D Maltby MA Correia, Biochemistry 2001 40 11318 11326 11560479
31. Regulation of cytochrome P450 by posttranslational modification. M Aguiar R Masse BF Gibbs, Drug Metab Rev 2005 37 379 404 15931769
32. Cytochrome P450 ubiquitination: branding for the proteolytic slaughter? MA Correia S Sadeghi E Mundo-Paredes, Annu Rev Pharmacol Toxicol 2005 45 439 464 15822184
33. Adenovirus endocytosis. U Meier OaG, J Gene Med 2003 5 451 462 12797110
34. Adenovirus-activated PKA and p38/MAPK pathways boost microtubule-mediated nuclear targeting of virus. M Suomalainen MY Nakano K Boucke S Keller UF Greber, EMBO J 2001 20 1310 1319 11250897
35. Integrin signaling in epithelial cells. MZ Gilcrease, Cancer Lett 2007 24 1 25
36. Integrins: signaling, disease, and therapy. S Huveneers H Truong HJ Danen, Int J Radiat Biol 2007 83 743 751 17852562
37. Structural basis of integrin regulation and signaling. BH Luo CV Carman TA Springer, Annu Rev Immunol 2007 25 619 647 17201681
38. Induction of drug metabolism by forskolin: the role of the pregnane × receptor and the protein kinase a signal transduction pathway. X Ding JL Staudinger, J Pharmacol Exp Ther 2005 312 849 856 15459237
39. Repression of PXR-mediated induction of hepatic CYP3A gene expression by protein kinase C. X Ding JL Staudinger, Biochem Pharmacol 2005 69 867 873 15710363
40. Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. MA Bogoyevitch B Kobe, Microbiol Mol Biol Rev 2006 70 1061 1095 17158707
41. Phosphorylation of the retinoid × receptor at the omega loop, modulates the expression of retinoic-acid-target genes with a promoter context specificity. N Bruck J Bastien G Bour A Tarrade JL Plassat A Bauer S Adam-Stitah C Rochette-Egly, Cell Signal 2005 17 1229 1239 16038797
42. Nuclear export of retinoid × receptor alpha in response to interleukin-1beta-mediated cell signaling: roles for JNK and SER260. TL Zimmerman S Thevananther R Ghose AR Burns SJ Karpen, J Biol Chem 2006 281 15434 15440 16551633
43. Endotoxin leads to rapid subcellular re-localization of hepatic RXRalpha: A novel mechanism for reduced hepatic gene expression in inflammation. R Ghose TL Zimmerman S Thevananther SJ Karpen, Nucl Recept 2004 2 4 15312234
44. The orphan nuclear receptor small heterodimer partner as a novel coregulator of nuclear factor-K-B in oxidized low density lipoprotein-treated macrophage cell line RAW 264.7. YS Kim CY Han SW Kim JH Kim SK Lee DJ Jung SY Park H Kang HS Choi JW Lee YK Pak, J Biol Chem 2001 276 33736 33740 11448950
45. Interleukin-1 beta-mediated suppression of RXR:RAR transactivation of the Ntcp promoter is JNK-dependent. D Li TL Zimmerman S Thevananther HY Lee JM Kurie SJ Karpen, J Biol Chem 2002 277 31416 31422 12105223
46. The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid × receptor transactivation: two mechanisms for repression. YK Lee H Dell DH Dowhan M Hadzopoulou-Cladaras DD Moore, Mol Cell Biol 2000 20 187 195 10594021
47. Identification of pregnane × receptor binding sites in the regulatory regions of genes involved in bile acid homeostasis. C Frank H Makkonen TW Dunlop M Matilainen S Väisänen C Carlberg, J Mol Biol 2005 46 505 519
48. Unveiling hidden features of orphan nuclear receptors: the case of the small heterodimer partner (SHP). A Macchiarulo G Rizzo G Costantino S Fiorucci R Pellicciari, J Mol Graph Model 2006 24 362 372 16288980
49. PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile. MA Croyle HT Le KD Linse V Cerullo G Toietta A Beaudet L Pastore, Gene Ther 2005 12 579 587 15647765
50. Improved system for helper-dependent adenoviral vector production. Da Palmer P Ng, Mol Ther 2003 8 846 852 14599819
51. The polypeptides of adenovirus I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. JV Maizel Jr DO White MD Scharff, Virol 1968 36 115 125
52. Development of a rapid method for the PEGylation of adenoviruses with enhanced transduction and improved stability under harsh storage conditions. MA Croyle QC Yu JM Wilson, Hum Gene Ther 2000 11 1713 1722 10954905
53. Controlled inactivation of recombinant viruses with vitamin B(2). SM Callahan P Wonganan LJ Obenauer-Kutner S Sutjipto JD Dekker MA Croyle, J Virol Methods 2008 148 132 145 18160141
54. Preparation of isolated rat liver cells. PO Seglen, Methods Cell Biol 1976 13 29 83 177845
55. The influence of L-glutamine on the depression of hepatic cytochrome P450 activity in male rats caused by total parenteral nutrition. AA Shaw SD Hall MR Franklin RE Galinsky, Drug Metab Dispos 2002 30 177 182 11792688
56. An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer. Y Yang SE Raper JA Cohn JF Engelhardt JM Wilson, Proc Nat Acad Sci USA 1993 90 4601 4605 7685107
57. Expression of nuclear hormone receptors, their coregulators and type I iodothyronine 5'-deiodinase gene in mammary tissue of nonlactating and postlactating rats. D Macejova M Baranova J Liska J Brtko, Life Sci 2005 77 2584 2593 15946693
58. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. TJ Wickham P Mathias DA Cheresh GR Nemerow, Cell 1993 73 309 319 8477447
59. The effect of high dose endotoxin on CYP3A2 expression in the rat. AL Roe G Warren G Hou G Howard SI Shedlofsky RA Blouin, Pharm Res 1998 15 1603 1608 9794504
60. Effect of low dose cyclosporine and sirolimus on hepatic drug metabolism in the rat. S Bai LJ Brunner SM Stepkowski KL Napoli BD Kahan, Transplantation 2001 71 1585 1592 11435969